The U.S. Food and Drug Administration (FDA) approved 13 drugs in September 2026, spanning first-in-class therapies, ...

For patients battling neurodegenerative diseases like ALS, Parkinson's, Alzheimer's and other dementias, delivering disease-fighting antibody drugs directly to the brain has proven to be a difficult ...

A new Alzheimer's disease prevention study has randomly assigned its first participant to a treatment group, helping researchers see if Alzheimer’s can be prevented in a population at the highest risk ...

The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, ...

Within three months of being diagnosed with asbestos-related lung cancer, Melvin Emms had died. His family, like hundreds of ...